Adaptive Biotechnologies Consensus Price Target Increased by 11.11% to $28.05
Published . Updated .
The average one-year price target for Adaptive Biotechnologies (NASDAQGS:ADPT) (MUN:1HM) has been revised to $28.05 / share. This is an increase of 11.11% from the prior estimate of $25.24 dated September 11, 2026. These figures represent an aggregate of analyst targets and do no
Directly affected
- ADPT Adaptive Biotechnologies
Named in this report.
Indirectly affected
- BTCZ T-Rex 2X Inverse Bitcoin Daily Target ETF
GA selected BTCZ as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- DOGG FT VEST DJIA DOGS 10 TARGET INCOME ETF
GA selected DOGG as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- FGSI FT VEST GROWTH STRENGTH & TARGET INCOME ETF
GA selected FGSI as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- ITDB ISHARES LIFEPATH TARGET DATE 2030 ETF
GA selected ITDB as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- ITDC ISHARES LIFEPATH TARGET DATE 2035 ETF USD
GA selected ITDC as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
Price reaction, T-5 to T+3
The average one-year price target for Adaptive Biotechnologies (NASDAQGS:ADPT) (MUN:1HM) has been revised to $28.05 / share. This is an increase of 11.11% from the prior estimate of $25.24 dated September 11, 2026. These figures represent…
Source: Nasdaq Markets
How far Adaptive Biotechnologies (ADPT) has moved since 2 Oct 2026
Since the first closing price after “Adaptive Biotechnologies Consensus Price Target Increased by 11.11% to $28.05,” Adaptive Biotechnologies (ADPT) is -19.83%. The S&P 500 fund (SPY) is -1.08% over the same days, a -18.75% difference versus the market.
Who gains and who loses around Adaptive Biotechnologies (ADPT)
Companies carried with this story
- ADPT Adaptive Biotechnologies
In “Adaptive Biotechnologies Consensus Price Target Increased by 11.11% to $28.05,” Adaptive Biotechnologies (ADPT) is linked, with no stored direction, medium confidence. Reason on file: GA selected ADPT as a RELATED security because its canonical security name directly matches this event's themes: biotechnologies, adaptive. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- BTCZ T-Rex 2X Inverse Bitcoin Daily Target ETF
For “Adaptive Biotechnologies Consensus Price Target Increased by 11.11% to $28.05,” T-Rex 2X Inverse Bitcoin Daily Target ETF (BTCZ) is linked, with no stored direction, medium confidence. Reason on file: GA selected BTCZ as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- DOGG Ft Vest Djia Dogs 10 Target Income Etf
Ft Vest Djia Dogs 10 Target Income Etf (DOGG) is linked, with no stored direction, medium confidence in the 2 Oct 2026 story “Adaptive Biotechnologies Consensus Price Target Increased by 11.11% to $28.05.” Reason on file: GA selected DOGG as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- FGSI Ft Vest Growth Strength & Target Income Etf
For “Adaptive Biotechnologies Consensus Price Target Increased by 11.11% to $28.05,” Ft Vest Growth Strength & Target Income Etf (FGSI) is linked, with no stored direction, medium confidence. Reason on file: GA selected FGSI as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- ITDB Ishares Lifepath Target Date 2030 Etf
For “Adaptive Biotechnologies Consensus Price Target Increased by 11.11% to $28.05,” Ishares Lifepath Target Date 2030 Etf (ITDB) is linked, with no stored direction, medium confidence. Reason on file: GA selected ITDB as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- ITDC Ishares Lifepath Target Date 2035 Etf Usd
For “Adaptive Biotechnologies Consensus Price Target Increased by 11.11% to $28.05,” Ishares Lifepath Target Date 2035 Etf Usd (ITDC) is linked, with no stored direction, medium confidence. Reason on file: GA selected ITDC as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
Adaptive Biotechnologies (ADPT)
The 2 Oct 2026 story “Adaptive Biotechnologies Consensus Price Target Increased by 11.11% to $28.05” names Adaptive Biotechnologies (ADPT) because of this story.
For Adaptive Biotechnologies (ADPT), the reason on file says GA selected ADPT as a RELATED security because its canonical security name directly matches this event's themes: biotechnologies, adaptive. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
Also listed, T-Rex 2X Inverse Bitcoin Daily Target ETF (BTCZ): GA selected BTCZ as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
Dates in the story, and the Adaptive Biotechnologies (ADPT) price range
ADPT traded between 23.86 and 30.74 across 20 sessions. The latest close on file is 23.94. BTCZ traded between 2.69 and 3.21 across 20 sessions. The latest close on file is 3.06. DOGG traded between 20.68 and 22.21 across 20 sessions. The latest close on file is 21.99.
A simple score for Adaptive Biotechnologies (ADPT)
46 out of 100
“Adaptive Biotechnologies Consensus Price Target Increased by 11.11% to $28.05” scores 46 out of 100. The score uses 1 sources, and 6 linked companies.